CORREVIO PHARMA CORP's ticker is CORV and the CUSIP is 22026V105. A total of 31 filers reported holding CORREVIO PHARMA CORP in Q4 2019. The put-call ratio across all filers is 0.54 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $78 | -4.9% | 200 | 0.0% | 0.00% | – |
| Q4 2019 | $82 | -79.5% | 200 | 0.0% | 0.00% | – |
| Q3 2019 | $400 | -7.4% | 200 | 0.0% | 0.00% | – |
| Q2 2019 | $432 | -31.6% | 200 | 0.0% | 0.00% | – |
| Q1 2019 | $632 | +26.9% | 200 | 0.0% | 0.00% | – |
| Q4 2018 | $498 | -38.1% | 200 | 0.0% | 0.00% | – |
| Q3 2018 | $804 | +6.3% | 200 | 0.0% | 0.00% | – |
| Q2 2018 | $756 | – | 200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tamarack Advisers, LP | 2,060,000 | $8,281,000 | 2.36% |
| Stonepine Capital Management, LLC | 898,157 | $3,611,000 | 2.11% |
| CLOUGH CAPITAL PARTNERS L P | 2,139,294 | $8,600,000 | 0.81% |
| Rock Springs Capital Management LP | 1,200,000 | $4,824,000 | 0.18% |
| ARS Investment Partners, LLC | 278,940 | $1,121,000 | 0.17% |
| WESTFIELD CAPITAL MANAGEMENT CO LP | 4,774,149 | $19,192,000 | 0.14% |
| Worth Venture Partners, LLC | 43,000 | $173,000 | 0.13% |
| PUTNAM INVESTMENTS LLC | 3,092,133 | $12,430,000 | 0.03% |
| Caption Management, LLC | 111,500 | $448,000 | 0.02% |
| ROYCE & ASSOCIATES LP | 254,900 | $1,025,000 | 0.01% |